Email Newsletters

Framingham

Holy Cross, WPI, Clark join colleges requiring COVID vaccines for fall semester

Students, faculty and staff wanting to participate in upcoming semesters must now be fully vaccinated against COVID-19 at Worcester schools the College of the Holy Cross, Clark University, and Worcester Polytechnic Institute.

Jack’s Abby opening pop-up beer garden in Boston

Framingham brewer Jack’s Abby Craft Lagers on Wednesday announced it will open a new, pop-up beer garden in Boston just in time for Memorial Day weekend.

Waters Corp. founder dies at age 95

James Waters, a Framingham resident and the founder of the $19-billion Milford laboratory equipment manufacturer Waters Corp., died on Monday at age 95, the company announced on Wednesday.

TJX returns to the black but store closures still an issue

Framingham’s TJX Cos. reported a turnaround in the first quarter of the 2022 fiscal year, with a 129% increase in net sales to $10.1 billion, but the company’s stock was still down amid ongoing store closures.
ADVERTISEMENT

Framingham firm to sell integrated Waters equipment

Framingham life sciences analytics technology firm SCIEX has announced it will begin offering Ultra-Performance Liquid Chromatography instruments from Milford lab equipment maker Waters Corp., integrated with its own mass spectrometry systems.

Bose launches direct-to-consumer hearing aids

Audio equipment manufacturer Bose, headquartered in Framingham, has announced new direct-to-consumer hearing aids that use an app to allow users to skip a doctor visit, hearing test or prescription.

Ameresco completes first European wind project

Clean energy company Ameresco, of Framingham, has completed its first European wind project, in Greece.

Ameresco first quarter profits rise 80%

Ameresco announced Tuesday it had profits of $11.2 million for the first quarter of the year, representing an 80% year-over-year increase compared to the first quarter of 2020.
ADVERTISEMENT

Arch Therapeutics names new CFO

Framingham biosurgical device manufacturer Arch Therapeutics, Inc., has named Michael Abrams its new chief financial officer.

Framingham and Czech partnership seeks new Alzheimer’s test

The Framingham pharmaceutical firm Alzheon has partnered with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences to develop a diagnostic assay to measure substances believed to be neurotoxic drivers of Alzheimer’s disease pathology.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA